| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 11 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 11 |
| 2 | TACROLIMUS OINTMENT 0.1% | 11 |
| 3 | PREDNISONE | 10 |
| 4 | METHYLPREDNISOLONE | 8 |
| 5 | MYCOPHENOLATE MOFETIL | 8 |
| 6 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 8 |
| 7 | RITUXIMAB | 6 |
| 8 | SIROLIMUS | 6 |
| 9 | VALGANCICLOVIR | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TREOSULFAN | 5 | 0.0018 |
| 1 | AVUTOMETINIB POTASSIUM AND DEFACTINIB HYDROCHLORIDE | 1 | 0.0009 |
| 2 | INTERFERON GAMMA-1B | 1 | 0.0007 |
| 3 | LIDOCAINE AND PRILOCAINE | 1 | 0.0007 |
| 4 | TALQUETAMAB-TGVS | 1 | 0.0007 |
| 5 | BELUMOSUDIL | 2 | 0.0006 |
| 6 | HYDROCORTISONE SODIUM SUCCINATE | 2 | 0.0005 |
| 7 | GLUCAGON | 2 | 0.0005 |
| 8 | DESLORATADINE | 5 | 0.0005 |
| 9 | SIROLIMUS | 6 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interferon gamma [EPC] | 1 | 0.0007 |
| 1 | Antihypoglycemic Agent [EPC] | 2 | 0.0005 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 6 | 0.0003 |
| 3 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 1 | 0.0002 |
| 4 | Human Immunoglobulin G [EPC] | 4 | 0.0002 |
| 5 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 6 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |
| 7 | Histamine-1 Receptor Antagonist [EPC] | 7 | 0.0001 |
| 8 | Leukotriene Receptor Antagonist [EPC] | 2 | 0.0001 |
| 9 | Azole Antifungal [EPC] | 8 | 0.0001 |